[{"address1": "Wagistrasse 14", "city": "Schlieren", "zip": "8952", "country": "Switzerland", "phone": "41 44 755 77 00", "fax": "41 44 755 77 07", "website": "https://www.molecularpartners.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Molecular Partners AG, a clinical-stage biotechnology company, develops designed ankyrin repeat proteins therapeutics for the treatment of oncology and virology diseases in Switzerland. The company develops MP0317, a CD40 agonist designed to activate immune cells within the tumor microenvironment by anchoring to fibroblast activation protein that is in Phase I clinical trial; and MP0533, a novel tetra-specific T cell-engaging DARPin for acute myeloid leukemia. It also develops Switch-DARPin platform, a multispecific cKIT x CD16a x CD47 Switch-DARPin program for targeted and conditional immune cell activation; and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has license and research collaboration agreements with Novartis Pharma AG to develop DARPin-conjugated radioligand therapies; and collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.", "fullTimeEmployees": 167, "companyOfficers": [{"maxAge": 1, "name": "Dr. Patrick  Amstutz Ph.D.", "age": 49, "title": "Co-Founder, CEO, Member of Management Board & Director", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 735475, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Tobias Stumpp Ph.D.", "age": 52, "title": "Co-Founder, Executive VP of Projects & Member of Management Board", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Hendriks", "title": "Senior VP of Finance", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander  Zurcher", "age": 49, "title": "COO & Member of Management Board", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Renate  Gloggner", "age": 54, "title": "Executive VP of People & Community and Member of Management Board", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Philippe  Legenne M.B.A., M.D.", "title": "Chief Medical Officer & Member of the Management Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Steiner Ph.D.", "title": "Senior Vice President of Research & Technology", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Seth D. Lewis", "title": "Senior Vice President of Investor Relations, Communications & Strategy", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Pitzner", "title": "General Counsel, Compliance Officer, Senior VP Legal & Business Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pamela A. Trail Ph.D.", "age": 68, "title": "Strategic Consultant", "yearBorn": 1956, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 4.57, "open": 4.6481, "dayLow": 4.6481, "dayHigh": 5.05, "regularMarketPreviousClose": 4.57, "regularMarketOpen": 4.6481, "regularMarketDayLow": 4.6481, "regularMarketDayHigh": 5.05, "payoutRatio": 0.0, "beta": 0.658, "forwardPE": -2.7336957, "volume": 2058, "regularMarketVolume": 2058, "averageVolume": 11047, "averageVolume10days": 840, "averageDailyVolume10Day": 840, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 185421408, "fiftyTwoWeekLow": 3.32, "fiftyTwoWeekHigh": 12.7, "priceToSalesTrailing12Months": 30.89327, "fiftyDayAverage": 5.14798, "twoHundredDayAverage": 5.562815, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 26095006, "profitMargins": 0.0, "floatShares": 4767991, "sharesOutstanding": 36863100, "sharesShort": 42600, "sharesShortPriorMonth": 44777, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0011999999, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.10797, "shortRatio": 13.59, "shortPercentOfFloat": 0.0016, "impliedSharesOutstanding": 37610400, "bookValue": 4.181, "priceToBook": 1.2030615, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -62591000, "trailingEps": -2.11, "forwardEps": -1.84, "enterpriseToRevenue": 4.348, "enterpriseToEbitda": -0.42, "52WeekChange": 0.16446579, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 5.03, "targetHighPrice": 16.943031, "targetLowPrice": 5.005594, "targetMeanPrice": 10.510008, "targetMedianPrice": 9.5814085, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 143618000, "totalCashPerShare": 4.327, "ebitda": -62162000, "totalDebt": 2747000, "quickRatio": 14.081, "currentRatio": 14.33, "totalRevenue": 6002000, "debtToEquity": 1.979, "revenuePerShare": 0.182, "returnOnAssets": -0.21174, "returnOnEquity": -0.37369, "grossProfits": -43963000, "freeCashflow": -38458248, "operatingCashflow": -62041000, "revenueGrowth": -0.732, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -21.42291, "financialCurrency": "CHF", "symbol": "MOLN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "messageBoardId": "finmb_32677064", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Molecular Partners AG", "longName": "Molecular Partners AG", "earningsTimestamp": 1741258740, "earningsTimestampStart": 1741258740, "earningsTimestampEnd": 1741258740, "earningsCallTimestampStart": 1741345140, "earningsCallTimestampEnd": 1741345140, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.11, "epsForward": -1.84, "epsCurrentYear": -1.605, "priceEpsCurrentYear": -3.1339564, "fiftyDayAverageChange": -0.11798, "fiftyDayAverageChangePercent": -0.022917727, "twoHundredDayAverageChange": -0.532815, "twoHundredDayAverageChangePercent": -0.095781535, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-16", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1740778557, "regularMarketTime": 1740776400, "regularMarketChangePercent": 10.065646, "regularMarketPrice": 5.03, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1623850200000, "postMarketChangePercent": -7.55467, "postMarketPrice": 4.65, "postMarketChange": -0.38, "regularMarketChange": 0.46000004, "regularMarketDayRange": "4.6481 - 5.05", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 11047, "fiftyTwoWeekLowChange": 1.7100003, "fiftyTwoWeekLowChangePercent": 0.5150603, "fiftyTwoWeekRange": "3.32 - 12.7", "fiftyTwoWeekHighChange": -7.6699996, "fiftyTwoWeekHighChangePercent": -0.603937, "fiftyTwoWeekChangePercent": 16.446579, "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]